Article first published online: 21 DEC 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 55, Issue 1, pages 307–315, January 2012
How to Cite
Ward, J. W., Lok, A. S.F., Thomas, D. L., El-Serag, H. B. and Kim, W. R. (2012), Report on a single-topic conference on “Chronic Viral Hepatitis–Strategies to Improve Effectiveness of Screening and Treatment”. Hepatology, 55: 307–315. doi: 10.1002/hep.24797
Potential conflict of interest: John W. Ward has no conflicts of interest. Anna Lok has been an advisor for Abbott, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Gilead, and Roche and has received grants from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Roche, and Merck. David Thomas has been a consultant for Merck and has received grants from Gilead and Merck. Hashem El-Serag has been a consultant for Vertex and has received grants from Bayer and Abbott. Ray Kim has been a consultant for Bristol-Myers Squibb and Gilead.
Financial Support: This single-topic conference was cosponsored by the American Association for the Study of Liver Diseases and the US Centers for Disease Control and Prevention.
- Issue published online: 21 DEC 2011
- Article first published online: 21 DEC 2011
- Accepted manuscript online: 22 NOV 2011 05:34AM EST
- Manuscript Accepted: 29 OCT 2011
- Manuscript Received: 17 SEP 2011
- American Association for the Study of Liver Diseases
- US Centers for Disease Control and Prevention
- 1Institute of Medicine. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: National Academies Press; January 11, 2010.
- 5Centers for Disease Control and Prevention. National, state and local area vaccination coverage among children aged 19-35 months—United States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59: 1171-1177.
- 6Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention. Comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults. MMWR Recomm Rep 2006; 55: 1-33., , , , , , et al.;
- 7Centers for Disease Control and Prevention. Surveillance for Viral Hepatitis - United States, 2009. http://www.cdc.gov/hepatitis/Statistics/2009Surveillance.
- 9Centers for Disease Control and Prevention. Hepatitis C virus infection among persons 15-24 years. Massachusetts, 2002-2009. MMWR Morb Mortal Wkly Rep 2011; 60: 537-541.
- 11Trust for America's Health/AASLD. HBV & HCV: America's Hidden Epidemics. Washington, DC: Trust for America's Health; 2010.
- 12US Department of Health and Human Services. Combating the Silent Epidemic: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis. Washington, DC: Department of Health and Human Services; 2011.
- 17Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; March 1, 2001.
- 18Centers for Medicare and Medicaid Services. 2010 Physician Quality Reporting Index, Version 4.0. Published November 13, 2009. Accessed November 2011. http://www.cms.hhs.gov/PQRI/Downloads/2010_PQRI_MeasuresLIst_111309.pdf
- 19Knowledge of hepatitis C screening and management by internal medicine residents: trends over 2 years. Am J Gastroenterol 2002; 97: 1216-1222., , , .Direct Link:
- 28Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral treatment evaluation and outcomes. Am J Gastroenterol 2006; 101: 2254-2262., , , , , , et al.Direct Link: